Two Vaccine Targets on Virus May Be Better Than One

An experimental vaccine developed by GeoVax Labs succeeded in promoting development of antibodies that target two different sites on the virus in a small pilot study.
Reuters Health Information

source https://www.medscape.com/viewarticle/970179?src=rss

Comments

Popular posts from this blog

Student Nurses Who Refuse Vaccination Struggle to Complete Degrees

The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors